论文部分内容阅读
自80年代以来,良性前列腺增生症(BPH)的治疗不再是以手术为唯一可选择的治疗方法,非手术的药物治疗日益受到重视。但药物治疗临床应用盲目性很大。我们对α阻滞剂和5α还原酶抑制剂治疗BPH的结果进行了比较,报告如下。 1.病例 随机选择门诊就诊BPH患者,根据B超检查前列腺增生重量<40g者60例,>40g者60例,分别分成两组,每组30例,共四组,全部病人均有不同程度的排尿困难。<40g者两组每组平均年龄61.5岁;62.1岁。>40g者两组平均年龄为64.7岁;66.2岁。
Since the 1980s, the treatment of benign prostatic hyperplasia (BPH) is no longer surgically the only alternative treatment, non-surgical medical treatment is increasingly valued. However, the clinical application of drug therapy blindness. We compared the results of BPH treatment with α-blocker and 5α-reductase inhibitors and are reported below. 1. Cases randomly selected outpatient visits BPH patients, according to B-ultrasound prostatic hyperplasia weight <40g in 60 cases,> 40g in 60 cases were divided into two groups, 30 cases in each group, a total of four groups, all patients have varying degrees of Difficulty urinating <40g, the average age of each group was 61.5 years old; 62.1 years old. > 40g, the average age of both groups is 64.7 years old; 66.2 years old.